 The journal ONCOLOGY is published monthly and is geared toward the practicing oncologist. It focuses on practical issues related to the care of patients with neoplastic disease. Topics covered may be either very broad or quite focused and, in general, are authored by a renowned expert in the particular area.
Its exceptionally wide circulation within the clinical cancer community insures broad exposure of its editorial material. In addition, ONCOLOGY is included in Medline, Excerpta Medica, EMBASE, and the Cancer Line and CancerLit databases at the National Cancer Institute.
Each article that appears in the journal is referred to one, two, or three reviewers, who are asked to write a short commentary to be published alongside the article. These commentaries broaden the reader's perspective on the topic being discussed as they serve to highlight areas of consensus or disagreement among professionals most familiar with the topic in question.
Subscriptions & Change of Address
Please direct your address changes, subscription, and cancellation requests for these publications to Colleen Tricarico. Mail and general correspondence relating to the above mention requests can be mailed to the following address:
Colleen Tricarico
CMPMedica
535 Connecticut Ave, Ste 300
Norwalk, CT
Phone: 203-523-7053
Fax: 203-842-3914
subscriptions@cmpmedica.com
Christopher Wees
Media Automation, Inc.
7745 2nd Avenue S
Minneapolis, MN 55423
Phone: 952-844-0512
Fax: 952-844-0017
cwees@mapub.com
Publishing and Sales Contacts
CancerNetwork.com Technical Questions
UBM Medica LLC
600 Community Drive
Manhasset, NY 11030
Phone: 516-734-2004
Fax: 516-734-2018 www.cancernetwork.com
JAMES O. ARMITAGE, MD
University of Nebraska Medical School, Omaha, Nebraska
NANCY E. DAVIDSON, MD
University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania
NORA JANJAN, MD
The University of Texas M. D. Anderson Cancer Center, Houston, Texas
WILLIAM C. WOOD, MD
Emory University School of Medicine, Atlanta, Georgia
NEIL K. AARONSON, PhD
Department of Psychosocial Research, The Netherlands Cancer Institute
DONALD I. ABRAMS, MD
San Francisco General Hospital, UCSF Osher Center for Integrative Medicine, San Francisco, California
FRANCIS ARENA, MD
Arena Oncology Associates, Great Neck, New York
JOSEPH S. BAILES, MD
Texas Oncology, Houston, Texas
LODOVICO BALDUCCI, MD
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida
RICHARD BARAKAT, MD
Gynecology Service Memorial Sloan-Kettering Cancer Center, New York, New York
CHARLES L. BENNETT, MD, PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
RONALD BLUM, MD
Beth Israel Medical Center, New York, New York
LINDA BOSSERMAN, MD
Wilshire Oncology Medical Group, Pomona, California
ROBERT W. CARLSON, MD
Stanford University Medical Center, Palo Alto, California
BARRIE CASSILETH, PhD
Integrative Medicine Service Memorial Sloan-Kettering Cancer Center, New York, New York
DAVID F. CELLA, PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
BRUCE D. CHESON, MD
Lombardi Cancer Center Georgetown University Medical Center, Washington, DC
EDWARD CHU, MD
Yale University School of Medicine, New Haven, Connecticut
LAWRENCE R. COIA, MD
East Coast Radiation Oncology Associates, Toms River, New Jersey
JAY S. COOPER, MD
Department of Radiation Oncology Maimonides Medical Center, Brooklyn, New York
E. DAVID CRAWFORD, MD
Division of Urology University of Colorado Health Sciences Center, Denver, Colorado
BARRY A. EAGEL, MD
Department of Medicine, University of Connecticut School of Medicine, Farmington, Connecticut
BURTON L. EISENBERG, MD
Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire
JOSHUA ELLENHORN, MD
City of Hope National Medical Center, Duarte California
PAUL F. ENGSTROM, MD
Vice President, Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania
WARREN E. ENKER, MD
Division of Colorectal Surgery, Beth Israel Medical Center, New York, New York
DAVID S. ETTINGER, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
KATHLEEN M. FOLEY, MD
Pain Service, Memorial Sloan-Kettering Cancer Center, New York, New York
ALISON FREIFELD, MD
Division of Infectious Diseases University of Nebraska, Omaha, Nebraska
RICHARD A. GAMS, MD
Prologue Research International, Columbus, Ohio
WILLIAM GRADISHAR, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
DANIEL G. HALLER, MD
Hematology-Oncology Section University of Pennsylvania, Philadelphia, Pennsylvania
JOHN T. HAMM, MD
University of Louisville, Kentucky
I. CRAIG HENDERSON, MD
Department of Medical Oncology, University of California, San Francisco, California
ROY S. HERBST, MD, PhD
Thoracic Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas
PAULO M. HOFF, MD
Centro Oncologico do Hospital Sirio-Libanes, Sao Paulo, SP, Brazil
JIMMIE C. HOLLAND, MD
Psychiatry Service Memorial Sloan-Kettering Cancer Center, New York, New York
GABRIEL N. HORTOBAGYI, MD
Department of Breast Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
WILLIAM J. HOSKINS, MD
Memorial Sloan-Kettering Cancer Center, New York, New York
V. CRAIG JORDAN, PhD, DSc
Medical Science Division Fox Chase Cancer Center, Philadelphia, Pennsylvania
M. JOHN KENNEDY, MD
St. James Hospital, Dublin, Ireland
ALLEN S. LICHTER, MD
American Society of Clinical Oncology, Alexandria, Virginia
JOHN MARSHALL, MD
Lombardi Comprehensive Cancer Center at Georgetown University, Washington, DC
MARY McCABE, RN
Memorial Sloan-Kettering Cancer Center, New York, New York
BRUCE D. MINSKY, MD
Pritzker School of Medicine University of Chicago Medical Center, Chicago, Illinois
MONICA MORROW, MD
Memorial Sloan-Kettering Cancer Center, New York, New York
JUDD W. MOUL, MD
Division of Urologic Surgery Duke University Medical Center, Durham, North Carolina
FRANCO M. MUGGIA, MD
Division of Oncology Kaplan Cancer Center, New York, New York
JAMES L. MULSHINE, MD
Rush University Medical Center, Chicago, Illinois
HYMAN B. MUSS, MD
Fletcher Allen Health Care, University of Vermont, Burlington, Vermont
M. STEVEN PIVER, MD
Sisters of Charity Hospital, Buffalo, New York
DAVID G. POPLACK, MD
Hematology-Oncology Service, Texas Children’s Hospital, Houston
RUSSELL K. PORTENOY, MD
Beth Israel Medical Center, New York, New York
LOUIS POTTERS, MD
Department of Radiation Oncology, North Shore-Long Island Jewish Health System, Rockville Centre, New York
TREVOR POWLES, MD
Parkside Oncology Clinic, Wimbledon, London
DEREK RAGHAVAN, MD, PhD
Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio
PETER M. RAVDIN, MD
University of Texas Health Sciences Center, San Antonio, Texas
STEVEN T. ROSEN, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois
MELANIE ROYCE, MD, PhD
University of New Mexico Cancer Research and Treatment Center, Albuquerque, New Mexico
RICHARD L. SCHILSKY, MD
University of Chicago, Chicago, Illinois
ANDREW D. SEIDMAN, MD
Breast and Gynecology/Oncology Service, Memorial Sloan-Kettering Cancer Center, New York, New York
THOMAS J. SMITH, MD
Medical College of Virginia, Massey Cancer Center, Richmond, Virginia
VERED STEARNS
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
N. SIMON TCHEKMEDYIAN, MD
Pacific Shores Medical Group, Long Beach, California
MARGARET A. TEMPERO, MD
University of California Medical Center, San Francisco, California
BHADRASAIN VIKRAM, MD
Clinical Radiation Oncology Branch National Cancer Institute, Rockville, Maryland
VINCENT VINCIGUERRA, MD
North Shore University Hospital, Manhasset, New York
VICTOR VOGEL, MD, MHS
American Cancer Society, Atlanta, Georgia
LAWRENCE D. WAGMAN, MD
Center for Cancer Prevention and Treatment, St. Joseph Hospital, Orange, California
LYNN D. WILSON, MD
Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut
SIDNEY WINAWER, MD
Gastroenterology and Nutrition Service, Memorial Sloan-Kettering Cancer Center, New York, New York
NORMAN WOLMARK, MD
Allegheny General Hospital, Pittsburgh, Pennsylvania
Susan Kweskin
Group Editorial Director
Andrew Nash
Associate Editorial Director and Managing Editor
Anne Landry
Executive Editor, ONCOLOGY Nurse Edition
Ronald Piana
Executive Editor, Special Projects
Angela Cibuls
Senior Editorial Coordinator and Project Manager
Amy Erdman
Director, Research, Marketing & Circulation
Cherie Gorman
Associate Art Director
Nancy Bitteker
Group Creative Director
Andrew Barkus
Production Manager
Sarah Mifsud
Account Manager, Digital Media
Amy Birnbach
Group Publisher, Oncology
Kathy Mischak
Group Publisher, Radiology
Marcy Holeton
Senior Vice President and General Manager
CMPMedica Corporate Officers
Henry Elkington
CEO, UBM Medica Ltd, UK
Patrick McAleenan
CFO, UBM Medica Ltd, UK
Phil Johnson
Group Publishing Director, Pharmacy, UK
Mary McGregor
Group Publishing Director, Medical, UK
Sally Shankland
CEO, UBM Medica USA
Steve Resnick
VP, Finance Director, USA
Edward Grossman
EVP, Professional Media, USA
Julia Murphy
VP, Director of Human Resources, USA
Pamela L. Moore, PhD
VP, Content & Strategy, USA
Morgan Kelsey
VP, Technology, USA
Ben Yeo
Managing Director, Asia
Ben Houdmont
CEO, Benelux
Kerri McCartney
CEO, Eastern Europe
Gérard Kouchner
CEO, France
Uwe Richter
CEO, Germany
Javier Sanz
General Manager, Iberia
Colin Abercrombie
CEO, New Zealand/Pacific
ONCOLOGY will not consider articles that are sponsored directly or indirectly by a commercial entity (eg, a pharmaceutical company or public relations firm). Financial Disclosure statements are published for all authors and reviewers. Specifications
1. Manuscript should be no more than 10 to 12 typed pages (plus tables, references, and illustrations), printed on 8½ x 11-inch paper, double-spaced, with 1½-inch margins. Submit an electronic copy (including tables and art elements) via e-mail to andrew.nash@cmpmedica.com or by mail on a CD, DVD, or IBM PC-compatible disk, preferably as a Microsoft Word document.
2. All abbreviations should be explained at first mention. Use of abbreviations should be kept to a minimum.
3. Drugs—If a drug is not available generically and is marketed as no more than two trademarked or registered products, both generic and trade names should be given. The first time a drug is mentioned, the generic name should be followed by the trade name in parentheses. Thereafter, only the generic name should be used.
4. The title page should include the title of the article, all authors’ names, their academic and clinical appointments, and their primary affiliations, city and state, plus an address for future correspondence. The second page should contain an abstract of 200 words or less, summarizing the main points of the paper and the major conclusions.
5. Printouts of photos and slides should be labeled “top” and numbered to correlate with the figure legends included in the manuscript. Where appropriate on scans, include arrows pointing to the pathology as part of the graphic. Figures should be provided as electronic files in high-resolution JPG, PDF, TIF, EPS, or PPT format. Each table should appear on a separate sheet, numbered and titled. All tables and figures should be cited in text in numerical order, with associated references (from credit lines or listed studies) included at the point of table/figure callouts.
6. References should be limited to 40 and numbered consecutively as they appear in the text. The following modifications of Medline style should be used:
For Articles:
Keime-Guibert F, Chinot O, Taillandier L, et al: Radiotherapy for glioblastoma in the elderly. N Engl J Med 356:1527-1535, 2007.
For Abstracts:
Hussein M, Berenson J, Niesvizky R, et al: Results of a phase I trial of SGN-40 (anti-huCD40 mAb) in patients with relapsed multiple myeloma (abstract 3576). Blood 108:1021a, 2006.
For Books:
Takimoto CH, Calvo E: Principles of oncologic pharmacotherapy, in Pazdur R, Coia LR, Hoskins WJ, et al (eds): Cancer Management: A Multidisciplinary Approach, 10th ed, pp 23-34. New York, CMPMedica, 2007.
For Web Citations:
National Cancer Institute: Melanoma risk assessment tool. Available at www.cancer.gov/melanomarisktool/. Accessed June 7, 2007.
Manuscripts and all accompanying material should be sent to:
Andrew Nash
ONCOLOGY
UBM Medica LLC
600 Community Dr, 3rd floor
Manhasset, NY 11030
Phone: (516) 734-2008
Fax: (516) 813-0966
e-mail: andrew.nash@cmpmedica.com
|
|
|
